Eirgen Pharma are a research-driven company that specialises in the development, manufacturing, and distribution of a wide range of high-potency oral solid dose (OSD) human and veterinary specialty products. We simplify the journey from molecule to market through cutting-edge research, development, and manufacturing. Our expertise lies in delivering specialty pharmaceutical solutions that meet the highest standards of quality, safety, and innovation.

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Drug Product Formulation (FDF);Research & Development;Clinical Trials materials and logistics;Packaging;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

3-5

High Potent Products capabilities:

OEB 4-5

Facilities Locations:

Europe

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);ISO;GMP;PMDA (Japan);Health Canada

Manufacturing Technologies:

Soft Gels;Solids

Company Products and Services:

CMO/CDMO

Current Capacity:

High capacity for new business 480M tablets, capsules, soft gel, liquid-filled hard cap